FOR W ARD LOOKING S T A TEMEN T : I n f orm a tion included he r ein co n t ains f o r w a r d looking s t a t eme n t s. F o r w a r d - looking s t a t eme n t s a r e ide n tified b y wo r ds such as ‘ ‘ e xpect , ’ ‘ ‘ plan , ’’ ‘ ‘ will , ’’ ‘ ‘ should , ’’ ‘ ‘ could , ’’ “ a n ticip a t e , ” “ estim a t e , ” and o ther similar e xp r e s sions. F o r w a r d - looking s t a t eme n t s i nv ol v e significa n t ris k s and uncer t ai n ties, including but n o t limi t ed t o the f ollowing: • Our independe n t audi t o r s h av e e xp r e s sed subs t a n tial dou b t about our abili t y t o co n tinue as a going concern, and we h av e a significa n t working capi t al d e ficit; • I f we f ail t o ef f ecti v ely manage our g r o w th, our busine s s and ope r a tions r esul t s could be harmed; • Our disclosu r e co n t r ols and p r ocedu r es a r e in ef f ecti v e, which could r esult in m a t erial mi s s t a t eme n t s in our financial s t a t eme n t s; • I n t ense competition in our indust r y ; • Our r eliance on a f ew major cus t ome r s; • Our r eliance on manageme n t and k e y pe r sonnel; • W e m a y be e xposed t o m a t erial p r oduct liabili t y claims; • Our insu r ance c ov e r age or thi r d par t y indemnific a tion rig h t s m a y n o t be su f ficie n t t o c ov er legal claims or o ther lo s ses th a t we m a y incur in the f u t u r e; • Our i n t ellec t ual p r oper t y rig h t s a r e v aluable and a n y cost t o p r o t ect them could r educe v alue o f our p r oduc t s and b r and; • W e h av e no manu f ac t uring capaci t y and a n ticip a t e co n tinued r eliance on thi r d - par t y manu f ac t u r e r s. In addition, past pe r f ormance is no gua r a n t ee o f f u t u r e pe r f ormance or r esul t s. All s t a t eme n t s or estim a t es made b y MusclePharm, o ther than s t a t eme n t s o f his t orical f act, r el a t ed t o m a tt e r s th a t m a y or will occur in the f u t u r e a r e f o r w a r d - looking s t a t eme n t s. R eade r s a r e encou r aged t o r ead the section e n titled “Risk F ac t o r s" in our December 3 1, 2 0 13 Annual R eport on F orm 10 - K and a n y and all o f our o ther docume n t s filed with the S E C r ega r ding i n f orm a tion about MusclePharm in r espect o f the f o r w a r d - looking s t a t eme n t s he r ein. I n t e r es t ed parties a r e able t o o b t ain copies o f filings co n t aining i n f orm a tion about MusclePharm without cha r ge, a t the S E C ’ s I n t ernet si t e ( h t tp: / / ww w .se c .g o v ). MusclePharm a s sumes no du t y t o upd a t e the f o r w a r d - looking s t a t eme n t s he r ein. D A TE : PRESENTE R : T A G L INE: A ugust 20 1 5 Richard E stalella, Preside n t Real A thletes. Real Scienc e ™

PG. 3 MUSCLEPHARM: FUELING THE ENGINE OF SPO R T™ BUSINESS Our goal is t o se r v e the needs o f all a thle t es, while f ueling the engine o f spor t s f or all ages and gende r s. MusclePhar m ’ s p r oduct lines a r e designed primarily f or specific a thletic use and a thle t es' needs, d a y in and d a y out. Comp r ehensi v e lines o f clinicall y - p r ov en, s a f e and ef f ecti v e nutritional suppleme n t s • A v ailable in mo r e than 1 10 cou n tries and av ailable in 35 , 000+ r e t ail outle t s • MusclePharm B r ands include MusclePharm® Hybrid Serie s ™ and Co r e Serie s ™, Arnold Sch w a rz enegge r ™ Series, and FitMi s s ™ • D ev eloped th r ough a si x - s t age r esea r ch p r oce s s th a t utili z es the e xpertise o f leading nutritional scie n tis t s, doc t o r s and uni v e r sities • 3 0, 000 squa r e - f o o t f acili t y MP Spor t s Science Insti t u t e, with in house R&D t eam led b y D r . Phillip F r ost, Chairman o f T ev a • T r aded under s ymbol M L SP; headquar t e r ed in De nv e r , Colo r ado

PG. 4 2 01 0 $150,000,00 0 $125,000,00 0 $ 11 0,87 7 ,591 $ 1 00,000,00 0 $75,000,000 $6 7 ,055,215 $50,000,000 $25,000,000 $ 1 7 ,212,636 $3,202,687 $ 1 75,000,00 0 $200,000,00 0 $220,000,00 0 2 01 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 15 E $ 1 7 7 ,289,00 0 $2 1 0,000,00 0 $220,000,00 0 BUI L T FROM THE GROUND UP W e a r e an a thle t e ’ s compa n y , run b y a thle t es who a r e pa s sion a t e about c r e a ting the world ’ s best nutritional and spor t s suppleme n t a tion p r oduc t s f or a thle t es • E s t ablished in 2008 • F ounded b y B r ad P ya t t ( f ormer NFL pl ay e r ) and Co r y G r ego r y (Nutrition indust r y leader and t op t r aining e xper t ) • G r ew f r om $3.2M in net r ev enue t o $ 1 7 7 .3 M in fi v e y ea r s

PG. 5 WEL L - E S T ABLISHED BA SE GROWING DI S TRIBUTION NETWORK • Our nutritional suppleme n t s a r e av ailable f or pu r chase in mo r e than 35 , 000 U .S. r e t ail outle t s, 100 online r e t ail outle t s, and mo r e than 1 10 i n t ern a tional cou n tries • P r o vides pl a t f orm t o launch additional p r oduc t s and p r oduct e x t ensions 120 48 K COUNTRI ES RE T AILE RS 100 + ONLINE RE T AILERS

PG. 6 A cco r ding t o the “Nutrition Busine s s Journal , ” The spor t s nutrition & weig h t lo s s mar k et in the Uni t ed S t a t es w as estim a t ed t o be app ro xim a t ely $37 billion in 2 0 1 4 . In r ece n t y ea r s, nutritional suppleme n t companies, anal y s t s, public a tions and o ther indust r y sou r ces h av e r e f e r enced a consis t e n t g r o w th r a t e o f be t ween 6% and 10% annuall y , particularly in t erms o f sales dollar g r o w th. The indust r y is e xpec t ed t o co n tinue t o g r ow a t a 6% t o 9% g r o w th r a t e ov er the p r ojec t ed g r o w th period 2 0 15 - 2 0 1 7 . CAPTURING A L ARGE AND GROWING MARKET 200 7 $20 Billion $40 Billion $60 Billion $80 Billion $ 1 00 Billion $120 Billion 2008 2009 2 01 0 2 01 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 01 6 2 0 1 7 $ 1 40 Billion $ 1 60 Billion GRO W TH B Y C A T E GO R Y : • The Mar k et is comprised o f Nutrition Ba r s a t 1 2 %, • Spor t s & Ene r gy Drin k s a t 56%, • Spor t s Nutrition Suppleme n t s a t 1 5 %, • W eig ht - L o s s Meal R eplaceme n t s a t 1 1 % and W eig ht - L o s s Pill - F orm Suppleme n t s a t 6%. MARKET TRENDS: • Inc r eased f ocus on fitne s s and healt h y living • Changing consumer beh a vior t o w a r ds new spor t s nutrition p r oduct f orm a t • Desi r e f or s a f e and ef f ecti v e p r oduc t s G L O B AL SPO R T S NUTRITION MARKET 20 0 7 - 2 0 13 PR O J EC TED * D a t a a cco r di n g t o N a t i o n al B u si n e s s Jour n al * * Al t h o u gh spec i f i c da t a f r om t h e f r a g m e nt ed i nt er na t i o n al m ar k e t s i s n o t r e a di l y av ai l ab l e, w e bel iev e simi l ar d e m og r aph i cs, ev e nt s a n d o t h er t r e nd s a f f ect t h e nu tr i t i o n al supp l e m e n t m ar k e t i nt er na t i o n al l y .

PG. 7 • E f f ecti v e Science - Based P r oduc t s • Our p r oduc t s a r e the r esult o f a si x - s t age p r oce s s i nv olving r ecogni z ed nutrition scie n tis t s, doc t o r s and p r o f e s sional a thle t es a t our MP Spor t s Science Insti t u t e • E v e r y p r oduct is a f ormul a tion th a t we, as f ormer p r o f e s sional a thle t es, beli ev e in and use ev e r y d a y OUR PRODUC TS: INCRE A SING MARKET SHARE LE G A C Y B UILD Y O UR R E A L A T H L E T ES. R E AL S C I E N CE. ™

PG. 8 T A G LINE R eal Science. R eal A thle t e s ™ T ARGET A UDIENCE • Prima r y Mar k et: Male 18 - 35 age g r oup • Seconda r y Mar k et: Male 3 5 + age g r oup L A UNCHED 2008 NUMBER OF PRODUC T S 15 PRODUC T S INC L UDE • Amin o 1 ™ • Armo r - V ® • A s sault • B a t tle F uel X T ™ • • • • Comb a t ® MuscleGel ® Sh r ed M a trix® R e - Con® AW ARD S • B r and Of Y ear • Glu t amine Of Y ear ( Glu t amin e ) • • • • • • P r e - W or k out o f Y ear ( A s saul t ) New Suppleme n t o f Y ear ( A s saul t ) P ac k aging o f Y ear Me n ’ s Support Suppleme n t o f Y ear (B a t tle F uel X T ) Rising S t ar o f Y ear RTD o f Y ear (MuscleGel) INTERN A TIONAL AW ARDS • B r azil: 2 0 13 B r and Of Y ear Major Sales G r o w th A w a r d * 2 0 1 4: B r and Of Y ea r , P r e - W or k out Of Y ear ( A s saul t ) DOME S TIC DI S TRIBUTER E u r opa Spor t s RE T AILER S • Ball y ’ s • Cos t co • Dic k s Sporting Goods • GNC • • • V i t amin Shoppe V i t amin W orld 2 4 Hour Fitne s s E - COMMERCE • Ama z on.co m • • BodyBuilding.co m V i t aCost.com INTERN A TIONA L 1 10 Cou n tries MUSCLEPH ARM HYBRID & CORE SERIES BRAND MES SA GE Scie n tificall y - ad v anced, pe r f ormance - dri v en suppleme n t s th a t c ov er all bases f or a thle t es and their wor k out needs. This line o f inn ova ti v e, Uni v e r si t y - t es t ed p r oduc t s help f uel a thle t es s a f ely b y inc r easing S t r ength, Endu r ance, H y d r a tion, R ec ov e r y , and ov e r all a thletic P e r f ormance. MP Hybrid Series p r oduc t s li k e A s sault, Amin o 1 and Comb a t® co n t ain ing r edie n t s th a t deli v er clinicall y - p r ov en pe r f ormance . MP Co r e p r oduc t s, such as B C A A 3 : 1 : 2 , CLA Co r e and Fish Oil, balance the e s se n tials t o meet the d a y - in and d a y - out demands o f a thle t es . PG. 8

PG. 9 T A G LINE S TRONG IS THE NEW SE X Y® T ARGET A UDIENCE • Prima r y Mar k et: F emale 25 - 45 age g r oup • Seconda r y Mar k et: F emale <25 age g r oup L A UNCHED 2 0 13 NUMBER OF PRODUC T S 8 PRODUC T S INC L UDE • FitMi s s Bur n ™ • FitMi s s Balanc e ™ • FitMi s s Cleans e ™ • FitMi s s Delig h t® • FitMi s s I gni t e ™ • FitMi s s T on e ™ • FitMi s s T y t e ™ • FitMi s s Z - Sli m ™ AW ARDS Nomin a t ed f or W ome n ’ s P r oduct o f Y ear (Delig h t®) DOME S TIC DI S TRIBUTER E u r opa Spor t s RE T AILERS • Ball y ’ s • Dic k s Sporting Goods • GN C • W alg r een s • V i t amin Shoppe • V i t amin W orld • 2 4 Hour Fitne s s E - COMMERCE • Ama z on.co m • Bodybuilding.co m • Drug St o r e.co m • V i t acost.com INTERN A TIONAL 35 Cou n tries FITMISS BRAND MES SA GE: Designed, dosed, and f ormul a t ed specifically f or the acti v e woma n ’ s li f es t yle utilizing clinically p r ov en ing r edie n t s th a t c ov e r s the r ange o f bu s y wome n ’ s needs, f r om including weig h t lo s s, multi - vi t amins, p r o t ein sha k es, de to x, skin ca r e, and p r e - wor k out ene r gy mi x es. Our doc t o r s f ormul a t ed these our p r oduc t s f or “he r ” women who also f ollow r egular wor k out r outines. A s working out and p r oper nutrition a r e the k e y s t o looking good and f eeling good.

PG. 10 T A G LINE Build Y our L egac y ™ T ARGET A UDIENCE: • Prima r y Mar k et: Male 18 - 45 age g r oup • Seconda r y Mar k et: Male 4 5 + age g r oup L A UNCHED 2 0 13 NUMBER OF PRODUC T S 7 PRODUC T S INC L UDE • I r on CR E3 ™ • I r on Cu t s ™ • I r on D r ea m ™ • I r on P ac k ™ • I r on Pum p ™ • I r on Ma s s ™ • I r on Wh ey ™ AW ARDS N /A DOME S TIC DI S TRIBUTER E u r opa Spor t s RE T AILERS • Ball y ’ s • Dic k s Sporting Goods • GNC • Gold ’ s Gym • V i t amin Shoppe • V i t amin W orld • 2 4 Hour Fitne s s • W inn Dixie E - COMMERCE • Ama z on.com • Bodybuilding.com • V i t acost.com INTERN A TIONAL 90 Cou n tries ARNOLD SCH W ARZENE GGER SERIES BRAND MES SA GE Cu t ting - edge p h y sique suppleme n t s t ailo r ed f or the fitne s s and bodybuilding e n thusias t s. Th e y a r e comprised o f p h y sique - enhancing ing r edie n t s li k e p r o t ein gaine r s, muscle builde r s, multivi t amins, and nitric o xide boos t e r s. Arnold Sch w a rz enegger wor k ed side - b y - side with MusclePharm® ’ s world - r enowned scie n tific t eam t o c r e a t e a line o f nutritional suppleme n t s th a t n o t only car r y his iconic name, but r ep r ese n t his li f elong commitme n t t o fitne s s and bodybuilding as well. PG. 10

PG. 11 CORE S TREN G THS 1. PRODUCING T OP QUALITY PRODUCTS 2. BA CKED B Y REAL A THLETES – REAL SCIENCE 3. CU ST OMER EXPERIENCE - UNM A T CHED CONNECTION WITH CU ST OMERS

PG. 12 E S T ABLISHING TRU S T : PRODUCING T OP QUALITY PRODUCTS • Insti t utional R e view Boa r d - app r ov ed clinical trials in - house a t the 3 0, 000 sq. ft. MusclePharm Spor t s Science Insti t u t e • Quali t y co n t r ol and scie n tific t eam comprised o f 20 scie n tis t s, pharmacis t s and doc t o r s • Scie n tific A dviso r y Boa r d: O v e r seen b y Scie n tific A dviso r y Boa r d led b y D r . R oscoe Moo r e, a f ormer A s sis t a n t U .S. Su r geon Gene r al and U .S. F ood and Drug A dminist r a tion Di r ec t o r , and D r . Phillip F r ost, chairman o f TE V A Pharmaceuticals. • A dditional clinical s t udies a r e pe r f ormed t o v alid a t e s a f e t y , ef ficacy and pe r f ormance th r ough the Uni v e r si t y o f North Ca r olina a t Chapel Hill, W ichi t a S t., A uburn Uni v e r si t y and o ther uni v e r sities • All p r oduc t s a r e certified b y I n f ormed Choice who is the world leader in Banned Subs t ance T esting ensuring th a t final p r oduct does n o t co n t ain a n y subs t ances banned b y sporting o r gani za tions globally

PG. 13 BUILDING THE BRAND: THE A THLETES COM P ANY ORGANIZ A TIONS: • O f ficial Suppleme n t o f U F C, now in ov er 800M homes Globally • O f ficial Suppleme n t o f U S A Wr estling • B r and Amba s sado r s: Arnold Sch w a rz enegge r , Collin K aepernick, Jen Sel t e r , T iger W oods

PG. 14 EARNING L O Y A L T Y : CONNECTING WITH CU ST OMERS W e h av e built one o f the st r ongest social communities in the indust r y • Daily W or k ou t s, T r aining A dvice and Diet Plans b y our A thle t es and MP Doc t o r s • Social Media & Cus t omer Command Ce n t er in Columbus, Ohio • P r o vides daily wor k ou t s, t r aining advice, diet plans, meals, r ecipes MUSCLEPH ARM 720K FITMIS S 660 K 340 K 290 K 300 K 1 40 K

PG. 15 CRE A TIN G A W AREN ESS: • O f ficial suppleme n t sponsor o f the Ultim a t e Fig h ting Championship • Sponso r ed ov er 100 U F C fig h t e r s including Ande r son Sil v a, Jon “Bone s ” Jones, Qui n t on “ R ampag e ” Jac k son, Cl a y Guida, and R ashad E v ans

PG. 16 GENER A TING BU ZZ

PG. 17 EX P AND CURRENT PRODUCT LINE • MusclePharm b r and will be launching ov er 75 new p r oduct of f erings in 2 0 1 4 • The FitMi s s b r and will be launching ov er 20 new p r oduct of f erings in 2 0 1 4 • The Arnold b r and will be launching ov er 40 new p r oduct of f erings in 2 0 1 4 GROW DI S TRIBUTION N A TIONAL L Y AND G L O B AL L Y • L ev e r age r e t ail and v endor partne r ships • Co n tinue t o b r and the MP name INCRE A SE AW ARENESS • Bring on additional a thle t e s / t ale n t t o mar k et new p r oduc t s • Co n tinue endo r seme n t s, sponso r ships and p r o viding samples th r ough g r a s s r o o t s mar k eting. DEVE L OP AND INTRODUCE NEW BRANDS • L ev e r age Bio Z one acquisition t echnology • Co n tinue t o l ev e r age distribution ne t work and d ev elop new channels GROWING THE COM P AN Y : CORE S TR A TEGIES

PG. 18 • A dded T iger W oods and John n y Manziel as our newest b r and amba s sado r ’ s • S t r engthened r e t ail p r esence with GNC • Published double – blind placebo – co n t r olled clinical trial co n firming s a f e t y and ef ficiency o f M P ’ s p r e - wor k out A s saul t ™ RECENT DEVELOPM ENTS

PG. 19 ENHANCING PROFI T ABILITY BUILDING V ALUE DRIVE REVENUE GRO W TH AND C A P TURE MARKET SHARE • Co n tinue building the b r and with new and ex citing p r oduc t s • High r e t e n tion with cus t ome r s th r ough one o f kind cus t omer e xperience • A dditional channels o f distribution • A dditional doo r s and mar k e t s ENHANCE PROFI T ABILI T Y B Y EX P ANDING MARGINS • Imp r ov e supply chain: Anal y z e inc r eme n t al v olume and o p timi z e pu r chase pricing • I n t r oduce p r oduct and line e x t ensions in spor t s nutrition a r eas th a t command higher ma r gins • V ertical i n t eg r a tion o f manu f ac t uring with - in the n e x t 18 mo n ths. 2 01 1 EP S GROSS MARGINS NET REVENUES 2 0 1 2 2 0 1 3 2 0 1 4 * $ 1 7 ,212,6 36 13.8 % ($70. 3 ) *ESTIM A T ED ($13. 0 ) ($2.5 ) $(1.25 ) 21 . 4 % 29.9 % 31.6 % $6 7 ,055,21 5 $ 11 0,8 7 7 ,5 9 1 $ 1 7 7 ,289,00 0 2 0 15 * $ ( 0 . 75 ) 3 1 % - 33% $2 1 0 M - $220 M

PG. 20 S TRONG GROW TH TRANSITIONING T O PROFI T ABILITY 0 2 0 14 2 0 15 2 0 13 2 0 12 2 0 1 1 NET REVENUE S GROSS MARGINS EPS $ 1 7 ,212 , 636 $6 7 , 055, 215 $1 1 0 ,8 7 7 , 5 9 1 $ 1 7 7 ,28 9, 000 $210M - $220M 1 3 .8 % 21 . 4 % 2 9 .9 % 3 1 . 6 % 3 2 % - 33% - $ 70 . 3 - $ 1 3. 0 - $2. 5 - $ 1.2 5 - $ 0 . 7 5

PG. 21 20 1 4 GLO B A L CHANNEL S ALES $ 1 7 7 MILLION SP E CIA L T Y INTERN A TIO NAL FD M 45 % 40 % 15 %

PG. 22 MUSCLEPH ARM TEAM BRAD P Y A T T CHIEF EX E CUTIVE OFFICER • F ounded MusclePharm® in 2008 a f t er pl a ying p r o f e s sional f o o tball f or s ev en y ea r s, the majori t y with the Indianapolis Col t s • Fi r sthand e xperience with t aking suppleme n t s t o enhance pe r f ormance • Bac k g r ound in kinesiology and ex e r cise science RICHARD E S T ALELLA PRESIDENT • Mo r e than 30 y ea r s o f e xperience, with e x t ensi v e knowledge in supply chain, r e t ail, distribution and w a r ehouse ope r a tions • F ormer Senior V ice P r eside n t o f Ope r a tions a t Arbonne I n t ern a tional, a skin ca r e and wellne s s p r oduc t s compa n y • F ormer Senior V ice P r eside n t o f W a r ehouse Ope r a tions o f O f fice Dep o t, whe r e he es t ablished ma n y o f the compa n y ’ s r e t ail mar k e t s, along with i t s n a tionwide distribution ce n t er ne t work JOHN PRICE CHIEF FINANCIAL OFFICER • Cur r e n t Chairman o f Disclosu r e Commi tt ee and Chi e f Risk Manageme n t O f fice r . • Ex t ensi v e e xperience a t public and pri va t e companies; including V ice P r eside n t o f Finance - North America a t Ope r a S o f tw a r e, V ice P r eside n t o f Finance and Corpo r a t e Co n t r oller a t G C T Semiconduc t or and T e s se r a T echnologies. • F ormer Ernst & Y oung LLP and is a Certified Public A ccou n t a n t ( cur r e n tly inacti ve ). JIM GREENWELL CHIEF OPER A TING OFFICER • Mo r e than 25 y ea r s o f manageme n t e xperience • F ormer MusclePharm Boa r d Member • F ormer V ice P r eside n t, V oice P r oduc t s f or I n t ellig r a t ed, Chairman and C E O o f the D a tria S y s t ems and Senior V ice P r eside n t, Sales and Mar k eting f or DecisionOne CO R Y GR E GO R Y EVP BRAND MAN A GEMENT - CO - F OUNDER • Ex t ensi v e e xperience and v arious accolades within s ev e r al a r eas o f the fitne s s indust r y • F e at u r ed on the c ov er o f t op fitne s s magazines, including Fitne s s RX and Inside Fitne s s • E x e r cise Specialist certific a t e f r om Columbus S t a t e, NE S T A nutrition coach certified, W es t side Barbell certified, C r o s sFit L ev el 1 t r ainer • A dvisor on Arnold Sch w a rz enegger Fitne s s A dviso r y Boa r d • F ormer unde r g r ound coal mine r , G r ego r y opened his own gym b y the age o f 20

PG. 23 SCIENTIFIC ADVISO R Y B O ARD DR. ERIC SERRAN O , M. D . M. D . – CHIEF F ORMUL A T OR & MEDI C AL A D VISOR • Conside r ed one o f the leading spor t s nutrition doc t o r s in the cou n t r y • Clie n t s include a wide ar r a y o f a thle t es f r om the NFL, NHL, and MLB; as well as eli t e am a t eur a thle t es • F ormul a t ed nume r ous nutritional suppleme n t s f or some o f the leading nutritional companies on the mar k et, including MusclePharm DR. ROSCOE M. MOORE, JR. CHIEF SCIENTIFIC DIR ECT OR • F ormer U .S. A s sis t a n t Su r geon Gene r al • Se r v ed with the Uni t ed S t a t es Departme n t o f Health and Human Se r vices (HH S ) • Principal pe r son r esponsible f or global d ev elopme n t support within the O f fice o f the Sec r e t a r y , HHS, with prima r y emphasis on Co n tine n t al Af rica and o ther le s s d ev eloped cou n tries o f the world DR. PHILLIP FRO S T , M. D . A D VISOR • Succe s sf ully f ounded s ev e r al pharmaceutical companies and ov e r see the d ev elopme n t and comme r ciali za tion o f a multi t ude o f pharmaceutical p r oduc t s • Chairman o f the Boa r d o f T ev a Pharmaceutical; Chairman o f the Boa r d o f L adenbu r g Thalmann Financial; Chairman o f the boa r d o f di r ec t o r s o f PRO L OR Bi o t ech; Di r ec t or o f Castle B r ands • F ormer Chairman o f the Departme n t o f Derm a t ology a t Mt. Sinai Medical Ce n t er o f G r e a t er Miami, Miami Beach, Chairman o f the Boa r d o f Di r ec t o r s o f K e y Pharmaceuticals • P r e viously se r v ed as Di r ec t or o f Co n tinuca r e Corpo r a tion, North r op Grumman Corp., I de a tion A cquisition Corp., P r o t alix Bio The r apeutics, In c ., and S a f e S ti t ch Medical In c ., and as G ov ernor and Co - V ice - Chairman o f the American S t ock E x change (now N Y SE Am e x). DR. S TEPHEN LI U , M. D . A D VISOR • Senior A dvisor f or The F r ost G r oup, and f or Cal Insti t u t e o f T echnology ( Cal T ech) Medical Engineering, whe r e he v e t s t echnology and i nv estme n t s f or the g r oups. • He has helped s ev e r al companies go public as well as e n t er i n t o st r a t egic partne r ships • Member o f the Boa r d o f Di r ec t o r s a t Ca r doMedical, Chairman a t I F G Health G r oup, P artner a t P acRim Capi t al G r oup, and boa r d member a t Cu r e Pharmaceutical

PG. 24 PG. 24 • L eading the industry with science - based p r oduc t s t es t ed f or s a f e t y and e f ficacy • L a r ge and g r owing mar k et, with inc r easing ado p tion o f MusclePharm b r ands • P r oduc t s c r e a t ed b y a thle t es f or a thle t es and p r om o t ed b y a thle t es • F ocus on cus t omer s a ti s f action and b r and loy al t y • No close competi t or in spor t s nutrition with the b r and awa r ene s s o f MusclePharm • St r ong g r o w th t r ajec t ory and p r ojec t ed t r ansition t o p r o fi t abili t y • Manageme n t t eam and adviso r s with unpa r alleled industry e xpertise WHY INVE S T